Literature DB >> 23010762

Proximal tubule angiotensinogen modulation of arterial pressure.

Nirupama Ramkumar1, Donald E Kohan.   

Abstract

PURPOSE OF REVIEW: Although the existence of a complete intrarenal renin-angiotensin system is now well established, its role in modulating tubule sodium transport and blood pressure is incompletely understood. Several recent studies have shed light on one component of the system, proximal tubule-derived angiotensinogen (AGT). This review discusses the synthesis, regulation and function of AGT in the proximal tubule. RECENT
FINDINGS: Under normal sodium intake, AGT within the S1 and S2 segments of the proximal tubule may derive from the systemic circulation, whereas the S3 segment synthesizes AGT. Urinary AGT likely primarily reflects proximal tubule-derived AGT. Proximal tubule AGT synthesis is regulated by high Na intake, angiotensin-II and inflammatory cytokines. Transgenic expression of mouse AGT in the proximal tubule causes hypertension. Overexpression of rat AGT in the proximal tubule leads to hypertension, enhanced reactive oxygen species generation via NADPH oxidase, tubular apoptosis and tubulointerstitial fibrosis; these effects can be mitigated by catalase overexpression.
SUMMARY: Proximal tubule-derived AGT has the potential to modulate blood pressure and sodium balance, and promote renal injury. Interactions with the systemic renin-angiotensin system may influence the role of proximal tubule-derived AGT in the kidney.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23010762      PMCID: PMC4164430          DOI: 10.1097/MNH.0b013e328359dbed

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  35 in total

1.  Elements of a paracrine tubular renin-angiotensin system along the entire nephron.

Authors:  A Rohrwasser; T Morgan; H F Dillon; L Zhao; C W Callaway; E Hillas; S Zhang; T Cheng; T Inagami; K Ward; D A Terreros; J M Lalouel
Journal:  Hypertension       Date:  1999-12       Impact factor: 10.190

2.  Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension.

Authors:  H Kobori; L M Harrison-Bernard; L G Navar
Journal:  Hypertension       Date:  2001-05       Impact factor: 10.190

3.  Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production.

Authors:  Hiroyuki Kobori; Lisa M Harrison-Bernard; L Gabriel Navar
Journal:  Kidney Int       Date:  2002-02       Impact factor: 10.612

4.  Androgen-dependent regulation of human angiotensinogen expression in KAP-hAGT transgenic mice.

Authors:  Y Ding; C D Sigmund
Journal:  Am J Physiol Renal Physiol       Date:  2001-01

5.  Effects of dietary sodium and genetic background on angiotensinogen and Renin in mouse.

Authors:  Pierre Lantelme; Andreas Rohrwasser; Barbu Gociman; Elaine Hillas; Tong Cheng; Gray Petty; Jennifer Thomas; Sha Xiao; Tomoaki Ishigami; Tracy Herrmann; Daniel A Terreros; Kenneth Ward; Jean-Marc Lalouel
Journal:  Hypertension       Date:  2002-05       Impact factor: 10.190

6.  Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice.

Authors:  R L Davisson; Y Ding; D E Stec; J F Catterall; C D Sigmund
Journal:  Physiol Genomics       Date:  1999-07-15       Impact factor: 3.107

7.  Liver angiotensinogen is the primary source of renal angiotensin II.

Authors:  Taiji Matsusaka; Fumio Niimura; Akihiro Shimizu; Ira Pastan; Akihiko Saito; Hiroyuki Kobori; Akira Nishiyama; Iekuni Ichikawa
Journal:  J Am Soc Nephrol       Date:  2012-04-19       Impact factor: 10.121

8.  Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors.

Authors:  János Peti-Peterdi; David G Warnock; P Darwin Bell
Journal:  J Am Soc Nephrol       Date:  2002-05       Impact factor: 10.121

9.  Is angiotensinogen a renin inhibitor and not the substrate for renin?

Authors:  K Poulsen; J Jacobsen
Journal:  J Hypertens       Date:  1986-02       Impact factor: 4.844

10.  Urinary angiotensinogen as an indicator of intrarenal Angiotensin status in hypertension.

Authors:  Hiroyuki Kobori; Akira Nishiyama; Lisa M Harrison-Bernard; L Gabriel Navar
Journal:  Hypertension       Date:  2003-01       Impact factor: 10.190

View more
  13 in total

1.  MicroRNA-133a-Dependent Inhibition of Proximal Tubule Angiotensinogen by Renal TNF (Tumor Necrosis Factor).

Authors:  Shoujin Hao; Joseph Salzo; Hong Zhao; Mary Hao; Zbigniew Darzynkiewicz; Nicholas R Ferreri
Journal:  Hypertension       Date:  2020-11-02       Impact factor: 10.190

Review 2.  Renin angiotensin aldosterone inhibition in the treatment of cardiovascular disease.

Authors:  Carlos M Ferrario; Adam E Mullick
Journal:  Pharmacol Res       Date:  2017-05-29       Impact factor: 7.658

Review 3.  The intrarenal generation of angiotensin II is required for experimental hypertension.

Authors:  Jorge F Giani; Kandarp H Shah; Zakir Khan; Ellen A Bernstein; Xiao Z Shen; Alicia A McDonough; Romer A Gonzalez-Villalobos; Kenneth E Bernstein
Journal:  Curr Opin Pharmacol       Date:  2015-01-21       Impact factor: 5.547

Review 4.  Remnant nephron physiology and the progression of chronic kidney disease.

Authors:  H William Schnaper
Journal:  Pediatr Nephrol       Date:  2013-05-29       Impact factor: 3.714

5.  Evidence of Augmented Intrarenal Angiotensinogen Associated With Glomerular Swelling in Gestational Hypertension and Preeclampsia: Clinical Implications.

Authors:  Hiten D Mistry; Lesia O Kurlak; David S Gardner; Ole Torffvit; Alastair Hansen; Fiona Broughton Pipkin; Helena Strevens
Journal:  J Am Heart Assoc       Date:  2019-06-25       Impact factor: 5.501

6.  Deletion of heterogeneous nuclear ribonucleoprotein F in renal tubules downregulates SGLT2 expression and attenuates hyperfiltration and kidney injury in a mouse model of diabetes.

Authors:  Kana N Miyata; Chao-Sheng Lo; Shuiling Zhao; Xin-Ping Zhao; Isabelle Chenier; Michifumi Yamashita; Janos G Filep; Julie R Ingelfinger; Shao-Ling Zhang; John S D Chan
Journal:  Diabetologia       Date:  2021-08-09       Impact factor: 10.122

7.  Activation of adenosine receptors improves renal antioxidant status in diabetic Wistar but not SHR rats.

Authors:  Daniela Patinha; Joana Afonso; Teresa Sousa; Manuela Morato; António Albino-Teixeira
Journal:  Ups J Med Sci       Date:  2013-11-06       Impact factor: 2.384

8.  Urinary angiotensinogen and urinary sodium are associated with blood pressure in normoalbuminuric children with diabetes.

Authors:  Jolanta Soltysiak; Bogda Skowronska; Piotr Fichna; Danuta Ostalska-Nowicka; Witold Stankiewicz; Maria Lewandowska-Stachowiak; Katarzyna Lipkowska; Jacek Zachwieja
Journal:  Pediatr Nephrol       Date:  2014-06-01       Impact factor: 3.714

9.  Suppressing kidney angiotensinogen in blood pressure regulation.

Authors:  Takamitsu Saigusa
Journal:  Physiol Rep       Date:  2016-02

10.  Effect of unilateral nephrectomy on urinary angiotensinogen levels in living kidney donors: 1 year follow-up study.

Authors:  Zeynep Kendi Celebi; Ahmet Peker; Sim Kutlay; Senem Kocak; Acar Tuzuner; Sehsuvar Erturk; Kenan Keven; Sule Sengul
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2017 Oct-Dec       Impact factor: 1.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.